Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.

OBJECTIVE Identification and characterization of calcium-sensing receptor (CASR) mutations in four unrelated Italian kindreds with familial hypocalciuric hypercalcemia. DESIGN Clinical evaluation and genetic analysis of CASR gene. Functional characterization of mutated CASRs. METHODS Direct sequencing of CASR gene in genomic DNA. Studies of CASR-mediated increases in cytosolic calcium concentration [Ca(2)(+)](i) in CASR-transfected COS-7 cells in vitro. RESULTS Four unreported heterozygous CASR mutations were identified, including three missense (H595Y, P748H, and C765W) and one splice site (IVS2+1G>C) mutation. The H595Y, P748H, and C765W mutant receptors, although expressed at normal levels on the cell surface, showed a reduced response in [Ca(2)(+)](i) relative to the wildtype (WT) CASR to increasing extracellular calcium concentrations. Cotransfection experiments showed that the H595Y and P748H mutants did not affect the apparent affinity of the WT CASR for calcium, suggesting that they do not exert a dominant-negative effect. On the other hand, the co-transfected C765W mutant decreased the maximum response of the WT CASR to calcium, suggesting that it may reduce the effective concentration of the normal CASR on the cell surface or impair its maximal signaling capacity. CONCLUSIONS Four CASR mutations were identified. The reduced functional responses to extracellular calcium and normal expression of the mutant receptors suggest that conformational changes account for altered CASR activity. Moreover, a reduced complement of normal CASRs in these heterozygous patients, perhaps combined with a mutant receptor-induced decrease in maximal activity of the WT receptor, may contribute to defective calcium-sensing in vivo.

[1]  D. Hoyer,et al.  Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors , 2005, Neuropharmacology.

[2]  J. Chudek,et al.  Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  G. Hendy,et al.  CASRdb: calcium‐sensing receptor locus‐specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia , 2004, Human mutation.

[4]  E. Brown,et al.  Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. , 2004, The New England journal of medicine.

[5]  L. Prézeau,et al.  The activation mechanism of class-C G-protein coupled receptors , 2004 .

[6]  E. Brown,et al.  Calcium: Extracellular calcium sensing and signalling , 2003, Nature Reviews Molecular Cell Biology.

[7]  C. Marcocci,et al.  Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss‐of‐function mutations in the calcium‐sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation , 2003, Clinical endocrinology.

[8]  山内 美香 Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene , 2003 .

[9]  J. Garber,et al.  A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. , 2003, The Journal of clinical endocrinology and metabolism.

[10]  J. Rastad,et al.  Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  J. Bollerslev,et al.  Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality? , 2002, The Journal of clinical endocrinology and metabolism.

[12]  M. Ranasinghe,et al.  The iBAC: an efficient high capacity genomic DNA expression system. , 2002 .

[13]  Y. Takeuchi,et al.  Inactivating Mutations of Calcium-Sensing Receptor Results in Parathyroid Lipohyperplasia , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[14]  G. Hendy,et al.  An acceptor splice site mutation in the calcium‐sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 2001, Human mutation.

[15]  T. Jap,et al.  A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent hypercalcemia and hypocalciuria. , 2001, The Journal of clinical endocrinology and metabolism.

[16]  E. Brown,et al.  Extracellular calcium sensing and extracellular calcium signaling. , 2001, Physiological reviews.

[17]  J. Rastad,et al.  Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  C. Marcocci,et al.  No Evidence for Mutations in the Calcium‐Sensing Receptor Gene in Sporadic Parathyroid Adenomas , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Thakker,et al.  Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. , 1999, American journal of human genetics.

[20]  G. Hendy,et al.  Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. , 1997, American journal of medical genetics.

[21]  E. Brown,et al.  Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. , 1996, The Journal of clinical investigation.

[22]  E. Brown,et al.  Expression and Characterization of Inactivating and Activating Mutations in the Human Ca2+o-sensing Receptor* , 1996, The Journal of Biological Chemistry.

[23]  S. Cannistraro,et al.  Effects of Somatostatin on Intracellular Calcium Concentration in PC12 Cells , 1996, Journal of neurochemistry.

[24]  J. Seidman,et al.  A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1995, Nature Genetics.

[25]  S. Pearce,et al.  Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. , 1995, The Journal of clinical investigation.

[26]  E. Brown,et al.  Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors. , 1995, The Journal of clinical endocrinology and metabolism.

[27]  J. Seidman,et al.  Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. , 1995, American journal of human genetics.

[28]  Z. Pausova,et al.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. , 1995, American journal of human genetics.

[29]  J. Seidman,et al.  Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism , 1993, Cell.

[30]  M. Leppert,et al.  Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. , 1993, American journal of human genetics.

[31]  W. M. Law,et al.  Parathyroid Glands in Familial Benign Hypercalcemia (Familial Hypocalciuric Hypercalcemia) , 1985 .

[32]  J. Auwerx,et al.  Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. , 1984, Acta endocrinologica.

[33]  R. Lasker,et al.  The Hypocalciuric or Benign Variant of Familial Hypercalcemia: Clinical and Biochemical Features in Fifteen Kindreds , 1981, Medicine.